An advisory panel has recommended the U.S. Food and Drug Administration approve Benlysta; it would be the first new drug approved to treat Lupus in over 50 years. Read more here.
New lupus drug one step closer to approval
The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.
Comments are closed.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
1 Comment.
my daughter has SLE 15 plus years.has doctors baffled because it’s also complicated with other autoimmune illnesses.She had two infusion of this benlysta and had a bad reactions where her fingers broke out in blisters and her hands were swollen.He wanted to continue and also start her on methylprednisolone to prep her before infusion.The risk was higher,there was no way of knowing what was going to happen,all we knew was it was not favorable.